SCHEMBL23469883

SCHEMBL23469883

CC(C)=Cc1cc(F)c(Oc2ccc(SNC=O)cc2)c(F)c1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SLC9A3 P48764 11/20 0.36
▸ TUBB1 Q9H4B7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24201229 0.76 SLC9A3 (0.48) SLC9A3
SCHEMBL20404624 0.75 SLC9A3 (0.36) SLC9A3TUBB1
SCHEMBL2595393 0.74 LTA4H (0.37) SLC9A3TUBB1
SCHEMBL24201173 0.73 LTA4H (0.33) SLC9A3
SCHEMBL24201220 0.72 SLC9A3 (0.36) SLC9A3
SCHEMBL19593632 0.72 SLC9A3 (0.42) SLC9A3TUBB1
SCHEMBL17991934 0.72 SLC9A3 (0.57) SLC9A3
SCHEMBL19593883 0.71 ESR1 (0.40) SLC9A3TUBB1
SCHEMBL19593445 0.71 SLC9A3 (0.41) SLC9A3TUBB1
SCHEMBL19593832 0.70 SLC9A3 (0.39) SLC9A3TUBB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3351248-B1 COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS ARDELYX INC (US) 2021-06-09 — — EP disclosed
Send feedback